Statin use and risk of nonmelanoma skin cancer: a nationwide study in Denmark

被引:0
|
作者
S Arnspang
A Pottegård
S Friis
O Clemmensen
K E Andersen
J Hallas
D Gaist
机构
[1] Clinical Pharmacology,Department of Clinical Chemistry & Pharmacology
[2] Institute of Public Health,Department of Public Health
[3] University of Southern Denmark,Department of Clinical Pathology
[4] Odense University Hospital,Department of Dermatology and Allergy Centre
[5] Danish Cancer Society Research Centre,Department of Neurology
[6] Faculty of Health,undefined
[7] Institute of Clinical Medicine,undefined
[8] Aarhus University,undefined
[9] University of Copenhagen,undefined
[10] Odense University Hospital,undefined
[11] Odense University Hospital,undefined
[12] Institute of Clinical Research,undefined
[13] Faculty of Health Sciences,undefined
[14] University of Southern Denmark,undefined
[15] Odense University Hospital,undefined
[16] Institute of Clinical Research,undefined
[17] Faculty of Health Sciences,undefined
[18] University of Southern Denmark,undefined
来源
British Journal of Cancer | 2015年 / 112卷
关键词
skin cancer; nonmelanoma; statins; risk; epidemiology; Denmark;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:153 / 156
页数:3
相关论文
共 50 条
  • [1] Statin use and risk of nonmelanoma skin cancer: a nationwide study in Denmark
    Arnspang, S.
    Pottegard, A.
    Friis, S.
    Clemmensen, O.
    Andersen, K. E.
    Hallas, J.
    Gaist, D.
    [J]. BRITISH JOURNAL OF CANCER, 2015, 112 (01) : 153 - 156
  • [2] Comment on "Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide caseecontrol study from Denmark''
    van Veelen, Ard
    Nielen, Johannes T. H.
    van Geel, Robin
    Croes, Sander
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (06) : E357 - E357
  • [3] Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark
    Pedersen, Sidsel Arnspang
    Gaist, David
    Schmidt, Sigrun Alba Johannesdottir
    Holmich, Lisbet Rosenkrantz
    Friis, Soren
    Pottegard, Anton
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (04) : 673 - +
  • [4] Reply to "Comment on 'Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide caseecontrol study from Denmark'''
    Pedersen, Sidsel Arnspang
    Potteg, Anton
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (06) : E359 - E360
  • [5] Mobile Phone Use and the Risk of Skin Cancer: A Nationwide Cohort Study in Denmark
    Poulsen, Aslak Harbo
    Friis, Soren
    Johansen, Christoffer
    Jensen, Allan
    Frei, Patrizia
    Kjaer, Susanne Kruger
    Dalton, Susanne Oksbjerg
    Schuz, Joachim
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2013, 178 (02) : 190 - 197
  • [6] Risk of Nonmelanoma Skin Cancer with Azathioprine Use
    Maddox, Jessica S.
    Soltani, Keyoumars
    [J]. INFLAMMATORY BOWEL DISEASES, 2008, 14 (10) : 1425 - 1431
  • [7] Risk of skin cancer in patients with vitiligo in Denmark: A nationwide cohort study
    Jorgensen, Mads Gustaf
    Toyserkani, Navid Mohamadpour
    Egeberg, Alexander
    Sorensen, Jens Ahm
    [J]. JAAD INTERNATIONAL, 2020, 1 (01): : 31 - 38
  • [8] Statin use and risk of skin cancer
    Lin, Brian M.
    Li, Wen-Qing
    Cho, Eunyoung
    Curhan, Gary C.
    Qureshi, Abrar A.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (04) : 682 - 693
  • [9] Use of hydrochlorothiazide and risk of melanoma and nonmelanoma skin cancer
    Rouette, Julie
    Yin, Hui
    Pottegard, Anton
    Azoulay, Laurent
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 570 - 570
  • [10] Statin use and risk of contralateral breast cancer: a nationwide cohort study
    Rikke Langballe
    Deirdre Cronin-Fenton
    Christian Dehlendorff
    Maj-Britt Jensen
    Bent Ejlertsen
    Michael Andersson
    Søren Friis
    Lene Mellemkjær
    [J]. British Journal of Cancer, 2018, 119 : 1297 - 1305